HCP (NYSE:HCP) Downgraded by ValuEngine to “Hold”

HCP (NYSE:HCP) was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued on Friday, February 2nd.

Other equities research analysts have also issued research reports about the company. Mizuho upgraded HCP from a “neutral” rating to a “buy” rating and set a $32.00 price objective for the company in a research note on Thursday, November 2nd. Stifel Nicolaus upgraded HCP from a “hold” rating to a “buy” rating and set a $29.00 price objective for the company in a research report on Tuesday, December 5th. Morgan Stanley restated an “equal weight” rating and set a $29.00 price objective on shares of HCP in a research report on Thursday, December 14th. Zacks Investment Research raised HCP from a “sell” rating to a “hold” rating in a research note on Thursday, November 9th. Finally, BMO Capital Markets reaffirmed a “hold” rating and set a $28.00 target price on shares of HCP in a research note on Wednesday, October 18th. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $30.14.

Shares of HCP (NYSE HCP) traded down $0.61 during trading hours on Friday, hitting $22.24. The company had a trading volume of 2,212,057 shares, compared to its average volume of 4,507,074. HCP has a 1-year low of $21.98 and a 1-year high of $33.67. The company has a current ratio of 0.61, a quick ratio of 0.61 and a debt-to-equity ratio of 1.17. The stock has a market cap of $10,888.01, a P/E ratio of 20.07, a P/E/G ratio of 4.20 and a beta of 0.27.

Large investors have recently made changes to their positions in the business. QS Investors LLC raised its holdings in HCP by 33.4% in the 2nd quarter. QS Investors LLC now owns 45,923 shares of the real estate investment trust’s stock valued at $1,468,000 after acquiring an additional 11,500 shares in the last quarter. Macquarie Group Ltd. grew its stake in shares of HCP by 4.3% in the 2nd quarter. Macquarie Group Ltd. now owns 1,543,697 shares of the real estate investment trust’s stock valued at $49,336,000 after purchasing an additional 64,241 shares during the period. State Street Corp grew its stake in shares of HCP by 0.3% in the 2nd quarter. State Street Corp now owns 27,363,119 shares of the real estate investment trust’s stock valued at $874,524,000 after purchasing an additional 74,972 shares during the period. BlueCrest Capital Management Ltd bought a new stake in shares of HCP in the 2nd quarter valued at approximately $3,099,000. Finally, Caxton Associates LP bought a new stake in shares of HCP in the 2nd quarter valued at approximately $495,000. 90.23% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: This piece of content was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/13/hcp-hcp-lowered-to-hold-at-valuengine.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply